Oral Oncology
Volume 37, Issue 7 , Pages 579-585 , October 2001

Alteration of pRb expression in the development of rat tongue carcinoma induced by 4-nitroquinoline 1-oxide

  • Shinya Niwa

      Affiliations

    • Graduate School of Dentistry, First Department of Oral and Maxillofacial Surgery, Osaka Dental University, 8-1 Kuzuhahanazono-cho, Hirakata-shi Osaka 573-1121, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-72-864-3080; fax: +81-72-864-3180
    • ,
  • Shigeru Ueno

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, Osaka Dental University, Osaka Dental University, 8-1 Kuzuhahanazono-cho, Hirakata-shi Osaka 573-1121, Japan
    • ,
  • Rikiya Shirasu

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, Osaka Dental University, Osaka Dental University, 8-1 Kuzuhahanazono-cho, Hirakata-shi Osaka 573-1121, Japan

Received 5 November 2000 ,Accepted 15 November 2000.

References 

  1. Ko LJ, Prives C. P53:puzzle and paradigm [Review] [245 refs]. Genes and Development. 1996;10(9):1054–1072
  2. Weinberg RA. Tumor suppressor genes. Science. 1991;254(5035):1138–1146
  3. Xu HJ, Hu SX, Cagle PT, Moore GE, Benedict WF. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Research. 1991;51(10):2735–2739
  4. Xu HJ, Quinlan DC, Davidson AG, Hu SX, Summers CL, Li J, et al.  Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. Journal of the National Cancer Institute. 1994;86(9):695–699
  5. Logothetis CJ, Xu HJ, Ro JY, Hu SX, Sahin A, Ordonez N, et al.  Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer [see comments]. Journal of the National Cancer Institute. 1992;84(16):1256–1261
  6. Trudel M, Mulligan L, Cavenee W, Margolese R, Cote J, Gariepy G. Retinoblastoma and p53 gene product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation. Human Pathology. 1992;23(12):1388–1394
  7. Kato H, Yoshikawa M, Fukai Y, Tajima K, Masuda N, Tsukada K, et al.  An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers. Anticancer Research. 2000;20(1A):345–349
  8. Pande P, Mathur M, Shukla NK, Ralhan R. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncology. 1998;34(5):396–403
  9. Koontongkaew S, Chareonkitkajorn L, Chanvitan A, Leelakriangsak M, Amornphimoltham P. Alterations of p53, pRb, cyclin D(1) and cdk4 in human oral and pharyngeal squamous cell carcinomas. Oral Oncology. 2000;36(4):334–339
  10. Bellacosa A, Almadori G, Cavallo S, Cadoni G, Galli J, Ferrandina G, et al.  Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clinical Cancer Research. 1996;2(1):175–180
  11. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y, Komiyama S. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Cancer. 1996;78(3):390–395
  12. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. American Journal of Pathology. 1995;146(5):1161–1169
  13. Zhang SY, Caamano J, Cooper F, Guo X, Klein-Szanto AJ. Immunohistochemistry of cyclin D1 in human breast cancer. American Journal of Clinical Pathology. 1994;102(5):695–698
  14. Sasano H, Frost AR, Saitoh R, Taniyama Y, Nagura H, Matsunaga G, et al.  Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma. Anticancer Research. 1997;17(5A):3685–3690
  15. Skomedal H, Kristensen GB, Lie AK, Holm R. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecologic Oncology. 1999;73(2):223–228
  16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 1976;72:248–254
  17. Ito K, Sasano H, Yoshida Y, Sato S, Yajima A. Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma. Anticancer Research. 1998;18(3A):1661–1664
  18. Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Molecular and Cellular Biology. 1994;14(3):1669–1679
  19. Shamma A, Doki Y, Shiozaki H, Tsujinaka T, Inoue M, Yano M, et al.  Effect of cyclin D1 and associated proteins on proliferation of esophageal squamous cell carcinoma. International Journal of Oncology. 1998;13(3):455–460
  20. Robles AI, Conti CJ. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis. 1995;16(4):781–786
  21. Matsumoto M, Furihata M, Ishikawa T, Ohtsuki Y, Ogoshi S. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma. British Journal of Cancer. 1999;80(1–2):256–261
  22. Linden MD, Torres FX, Kubus J, Zarbo RJ. Clinical application of morphologic and immunocytochemical assessments of cell proliferation [editorial]. American Journal of Clinical Pathology. 1992;97(Suppl. 1):S4–13
  23. Lee CC, Yamamoto S, Wanibuchi H, Wada S, Sugimura K, Kishimoto T, et al.  Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation. Cancer Research. 1997;57(21):4765–4776
  24. Wang QS, Papanikolaou A, Sabourin CL, Rosenberg DW. Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis. Carcinogenesis. 1998;19(11):2001–2006
  25. Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, et al.  The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Research. 1996;56(23):5475–5483
  26. Xu HJ, Hu SX, Benedict WF. Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level. Oncogene. 1991;6(7):1139–1146
  27. Kumar R, Atlas I. Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation. Proceedings of the National Academy of Sciences of the United States of America. 1992;89(14):6599–6603

PII: S1368-8375(00)00141-X

Oral Oncology
Volume 37, Issue 7 , Pages 579-585 , October 2001

Article Tools

* Image Usage & Resolution